Skip to main content
Premium Trial:

Request an Annual Quote

Lighthouse Lab Services Molecular Saliva Test for SARS-CoV-2 Gets FDA Emergency Use Authorization

NEW YORK – Lighthouse Lab Services received Emergency Use Authorization from the US Food and Drug Administration this week for a lab-based molecular saliva test for SARS-CoV-2.

Lighthouse received EUA for its SalivaNow SARS-CoV-2 assay, which is intended for detection in saliva of SARS-CoV-2 nucleic acid in individuals suspected by their healthcare provider of being infected with the virus.

The test is a real-time PCR assay. It can be run in laboratories that meet CLIA requirements for high-complexity testing.